Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
Status:
Withdrawn
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
The objectives of PROVIDE are to:
1. Determine if prophylactic once weekly hydroxychloroquine reduces the incidence of
conversion from SARS-2-CoVnasopharyngeal swab negative to positive
2. To determine if weekly prophylactic hydroxychloroquine reduced the severity of COVID-19
symptoms
3. To determine the safety of taking weekly prophylactic hydroxychloroquine